Atherosclerotic renal artery stenosis: Overtreated but underrated?

Research output: Contribution to journalComment/debatepeer-review

48 Scopus citations


Despite evidence of only moderate clinical benefit, application of renal endovascular stent procedures has increased at least four-fold in the past decade. Medicare is reviewing national coverage regarding reimbursement, questioning whether outcome data warrant many of these procedures. Several prospective, randomized trials are now in progress to compare outcomes with optimized medical therapy with and without stenting. Current imaging methods establish primarily the presence and severity of vascular occlusive disease. Optimal treatment for individual patients remains in flux and is reviewed here. Most important, nephrologists await development of tools to predict reliably when renal parenchymal injury is beyond recovery and/or when revascularization can produce meaningful salvage of kidney function.

Original languageEnglish (US)
Pages (from-to)656-659
Number of pages4
JournalJournal of the American Society of Nephrology
Issue number4
StatePublished - Apr 2008

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Atherosclerotic renal artery stenosis: Overtreated but underrated?'. Together they form a unique fingerprint.

Cite this